Extensive impact of non-antibiotic drugs on human gut bacteria
By Lisa Maier, M. Pruteanu, Michael Kuhn, Georg Zeller, Anja Telzerow, E. E. Anderson, Ana Rita Brochado, K. Fernandez, Hitomi Dose, Hirotada Mori and 3 more. Nature, 2018
1,691 citations recorded by the source corpus.
A few commonly used non-antibiotic drugs have recently been associated with changes in gut microbiome composition, but the extent of this phenomenon is unknown. Here, we screened more than 1,000 marketed drugs against 40 representative gut bacterial strains, and found that 24% of the drugs with human targets, including members of all therapeutic classes, inhibited the growth of at least one strain in vitro. Particular classes, such as the chemically diverse antipsychotics, were overrepresented in this group. The effects of human-targeted drugs on gut bacteria are reflected on their antibiotic-like side effects in humans and are concordant with existing human cohort studies. Susceptibility to antibiotics and human-targeted drugs correlates across bacterial species, suggesting common resistance mechanisms, which we verified for some drugs. The potential risk of non-antibiotics promoting antibiotic resistance warrants further exploration. Our results provide a resource for future research on drug–microbiome interactions, opening new paths for side effect control and drug repurposing, and broadening our view of antibiotic resistance.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/75e2335efbe22370992a4f3310fbeaf9626db7a0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Role of gut microbiota in type 2 diabetes pathophysiology (2020, background): “It is well known that antibiotics [122,123], non-antibiotic drugs [124] and anti-diabetic drugs (Table 2) can modulate microbiota and improve diabetes.”